A Study of Ziprasidone for the Treatment of Psychosis in Patients Who Had Already Had Benefits From Ziprasidone Treatment in a Previous Study
Clinical trial NCT00645320 · COMPLETED
Trial details
- NCT number
- NCT00645320
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.